文献速递骨质疏松与钙磷/甲状旁腺

基因组分析揭示中国人群散发性甲状旁腺腺瘤的变异图谱

Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

该研究对73例甲状旁腺腺瘤(PA)患者进行全外显子测序,在1549个基因中检出体细胞变异,平均每例肿瘤69个变异(范围13-2109;总计9083个)。除已知PA相关基因外,发现KMT2D(15/73)等新复发变异,KMT2D可能是候选驱动基因;5例携带CDC73体细胞突变者呈侵袭性表型,类似甲状旁腺癌(PC),且parafibromin表达降低。通路分析显示复发潜在PA驱动基因富集于Notch信号通路。

要点

  • 在73例中国散发性PA中鉴定出1549个基因的体细胞变异,KMT2D(15/73)可能是候选驱动基因。
  • 5例携带CDC73体细胞突变者呈侵袭性表型,类似PC,parafibromin表达降低。
  • 复发潜在PA驱动基因富集于Notch信号通路。

核心结论

  • 本研究扩展了PA的致病变异谱,提示KMT2D可能是新的候选驱动基因,并可作为PA的诊断生物标志物。
  • CDC73突变可能是PA向PC发展的早期事件。

研究设计与样本

  • 收集73例PA患者的基本临床特征和生化指标。
  • 对匹配的肿瘤-体质DNA配对进行全外显子测序以检测体细胞变异。
  • 随后用ingenuity通路分析进行功能注释。
  • 通过免疫组织化学确认变异基因的蛋白表达,并分析基因型与表型的关系。

主要发现

  • 在1549个基因中鉴定出体细胞变异,平均每例肿瘤69个变异(范围13-2109;总计9083个)。
  • 检测到多个新的复发体细胞变异:KMT2D(15/73)、MUC4(14/73)、POTEH(13/73)、CD22(12/73)、HSPA2(12/73)、HCFC1(11/73)、MAGEA1(11/73)、SLC4A3(11/73)。
  • 除先前报道的PA相关基因外,还检出MEN1(11/73)、CASR(6/73)、MTOR(4/73)、ASXL3(3/73)、FAT1(3/73)、ZFX(5/73)、EZH1(2/73)、POT1(2/73)、EZH2(1/73)。
  • 5例患者携带CDC73体细胞突变,表现出类似PC的侵袭性表型,且parafibromin表达降低。
  • 复发潜在PA相关驱动变异基因的通路分析显示功能富集于Notch信号通路。

临床怎么用

  • 作者认为KMT2D可能是新的候选驱动基因,并可作为PA的诊断生物标志物。
  • 作者认为CDC73突变可能是PA向PC发展的早期事件。
  • 研究结果为阐明甲状旁腺肿瘤发生的发病机制提供了见解,并为临床诊断和治疗提供了一定基础。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To define somatic variants of parathyroid adenoma (PA) and to provide novel insights into the underlying molecular mechanism of sporadic PA. METHODS: Basic clinical characteristics and biochemical indices of 73 patients with PA were collected. Whole-exome sequencing was performed on matched tumor-constitutional DNA pairs to detect somatic alterations. Functional annotation was carried out by ingenuity pathway analysis afterward. The protein expression of the variant gene was confirmed by immunohistochemistry, and the relationship between genotype and phenotype was analyzed. RESULTS: Somatic variants were identified in 1549 genes, with an average of 69 variants per tumor (range, 13-2109; total, 9083). Several novel recurrent somatic variants were detected, such as KMT2D (15/73), MUC4 (14/73), POTEH (13/73), CD22 (12/73), HSPA2 (12/73), HCFC1 (11/73), MAGEA1 (11/73), and SLC4A3 (11/73), besides the previously reported PA-related genes, including MEN1 (11/73), CASR (6/73), MTOR (4/73), ASXL3 (3/73), FAT1 (3/73), ZFX (5/73), EZH1 (2/73), POT1 (2/73), and EZH2 (1/73). Among them, KMT2D might be the candidate driver gene of PA. Crucially, 5 patients carried somatic mutations in CDC73, showed an aggressive phenotype similar to that of parathyroid carcinoma (PC), and had a decreased expression of parafibromin. Pathway analysis of recurrent potential PA-associated driver variant genes revealed functional enrichments in the signaling pathway of Notch. CONCLUSION: Our study expanded the pathogenic variant spectrum of PA and indicated that KMT2D might be a novel candidate driver gene and be considered as a diagnostic biomarker for PA. Meanwhile, CDC73 mutations might be an early developmental event from PA to PC. The results provided insights into elucidating the pathogenesis of parathyroid tumorigenesis and a certain basis for clinical diagnosis and treatment.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Tao X, Xu T, Lin X, et al. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population. J Clin Endocrinol Metab. 2023. PMID: 36611251. doi:10.1210/clinem/dgad002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。